MARKET

CYTH

CYTH

Cyclo Therapeutics Inc
NASDAQ
1.280
-0.008
-0.61%
Closed 17:41 05/30 EDT
OPEN
1.370
PREV CLOSE
1.288
HIGH
1.370
LOW
1.270
VOLUME
29.34K
TURNOVER
--
52 WEEK HIGH
2.750
52 WEEK LOW
0.6700
MARKET CAP
19.42M
P/E (TTM)
-0.6991
1D
5D
1M
3M
1Y
5Y
Cyclo Therapeutics Inc: Current report
Press release · 05/20 08:25
Cyclo Therapeutics Inc: Statement of changes in beneficial ownership of securities
Press release · 05/20 08:25
BRIEF-Cyclo Therapeutics - On May 15, Co Got Letter From Nasdaq Stating That Co Was Not In Compliance With Nasdaq Listing Rule
Reuters · 05/18 21:24
Cyclo Therapeutics reports Q1 results
Seeking Alpha · 05/15 14:26
BRIEF-Cyclo Therapeutics Provides Business Update And Reports First Quarter 2023 Financial Results
Reuters · 05/15 12:11
Anavex And The Antioxidant Treatment Of Alzheimer's Disease
Seeking Alpha · 05/04 12:00
Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/26 12:37
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 04/25 17:33
More
About CYTH
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is a treatment for Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. Its product lines include Trappsol and Aquaplex. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The Company sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors.

Webull offers kinds of Cyclo Therapeutics Inc stock information, including NASDAQ:CYTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYTH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYTH stock methods without spending real money on the virtual paper trading platform.